Real
Account name
Test cent
Broker
Exness
Currency / Leverage
USC · 1:2000000000
Account status
Verified
Started
Jun 25, 2024
Trading style
—
Strategy
—
Last synced
10/9/26, 3:09 PM (3 hours ago)
Order type
EA + manualEA 18%1,505 orders
Manual 82%6,912 orders
Determined from the magic number on the real orders — an order opened by an EA carries the EA's identifier, one opened by hand does not
Loading chart…
AI analysis
1.8
/10
Accuracy
6.4
Profitability
2.7
Risk control
0.1
Consistency
0
Recovery
0
A scalper trading XAUUSDc with extreme frequency — 8,257 trades and a 64% win rate — still lost over ¢53,000 because the average loss (-88.4) was more than double the average win (+40.62), compounded by 208 revenge-trading episodes and 530 instances of overleveraging.
Strengths
3Consistently high win rate
63.51% overall win rate across 8,274 trades; Long 65.56%, Short 60.46%
Strong profitability from 00:00–12:00
00–03: 77% win, +¢1,831; 06–09: 68% win, +¢805; 09–12: +¢3,362
Longest winning streak hit 128
Shows the system has periods of exceptionally high accuracy
Weaknesses
3Inverted risk-reward
Average win +40.62 vs. average loss -88.4 — losses are 2.2× larger than wins
Extremely high frequency but net negative
8,257 XAUUSDc trades, net P&L -¢53,263.8, averaging -6.45 per trade
Thursdays and the 21:00–00:00 window are brutal
Thursday loss ¢19,150; 21–00: only 57% win rate, -¢23,781
Risks
2Repeated revenge trading
208 instances of opening volume >2× within 10 minutes of a loss
Frequent overleveraging
530 instances where volume spiked beyond 2 standard deviations from the mean
Suggested improvements
3- 1
Cut lot size in half immediately after 3 consecutive losses
Average loss is 2.2× the average win — must break the revenge cycle
- 2
Stop trading during 21:00–00:00
Only 57% win rate in this window, with a loss of ¢23,781
- 3
Set SL so the loss never exceeds 1.5× the TP
Current risk-reward is inverted: -88.4 vs. +40.62
Calculating statistics…
Loading chart…
Loading advanced statistics…
Loading trade history…
Loading comments…
